FRATES JAMES M (Chief Financial Officer) sold 4.4% of their position (10.81K shares) of AMYLYX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $349.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/14/2026ACC: 0001193125-26-390509
Officer· Chief Financial Officer
Since Jan 2022
-10.81K
Net shares
Net seller
$349.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.77K
Price / share
$32.27
Trade value
$315.19K
% of position
4.0%
9/10/2026
244.44K→234.67K
Common Stock
Direct
Shares
−1.04K
Price / share
$33.23
Trade value
$34.63K
% of position
0.4%
9/10/2026
234.67K→233.63K
Total
Net shares
−10.81K
Net value
-$349.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | S · Sale | −9.77K | $32.27 | $315.19K | 4.0% | 244.44K | 234.67K |
| Common Stock Direct | 9/10/2026 | S · Sale | −1.04K | $33.23 | $34.63K | 0.4% | 234.67K | 233.63K |
| Total | −10.81K | -$349.82K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned100K
Common Stock
IndirectShares owned40K
Common Stock
IndirectShares owned11.07K
Common Stock
IndirectShares owned15.46K
Total
166.53K indirect166.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100K | Indirect |
| Common Stock | 40K | Indirect |
| Common Stock | 11.07K | Indirect |
| Common Stock | 15.46K | Indirect |
| Total | 166.53K | 166.53K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported